Clinical trials: Maxillary Cyst
Maxillary Cyst, Bone Loss of Substance
Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H)
This trial pretends to validate for clinical use a bioengineered product composed of MSV cells (mesenchymal stem cells produced by IBGM, Valladolid, which have already been approved by the Spanish Regulatory Agency for three…
- Trial name
- BIOMAX (NCT01389661)
- Testing
- MSV treatment
- Where
- 3 sites in Spain
- Volunteers
- 11 people
- Sponsor
- Red de Terapia Celular